Brainstorm Cell
Hackensack, US · 1 known investors
BrainStorm Cell Therapeutics develops NurOwn, an autologous MSC-NTF cellular therapy platform aimed at treating neurodegenerative diseases with limited treatment options. Its cell therapy is investigational and not yet FDA approved.
BiotechHealthtechMedical Devices
Founders & leadership
AF
Anthony FiorinoExecutive
UY
Uri YablonkaExecutive
LS
Liat SossoverExecutive
CL
Chaim LebovitsExecutive
IA
Irit ArbelNamed on SEC filing
MT
Malcolm TaubNamed on SEC filing
Board
MF
Mordechai FriedmanBoard director
AP
Alon PinkasBoard director
CS
Chen SchorBoard director
RS
Robert ShorrBoard director
MS
Malcolm S. TaubBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$12.1M disclosed across 2 of 5 rounds · 2014–2019
▶Undisclosed amountofferedAug 2019 · 3 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedAug 2019 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ralph KernExecutive Officer
- Dr. Anthony PolverinoDirector
- Chen SchorDirector
- Arturo ArayaExecutive Officer
- Dr. June AlmenoffDirector
- Dr. Irit ArbelDirector
- Malcolm TaubDirector
- Chaim LebovitsExecutive Officer
- Eyal RubinExecutive Officer
- Uri YablonkaExecutive Officer, Director
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedJun 2018 · 6 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedJun 2018 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dr. Anthony PolverinoDirector
- Uri YablonkaExecutive Officer, Director
- Chaim LebovitsExecutive Officer
- Ralph KernExecutive Officer
- Dr. June AlmenoffDirector
- Dr. Irit ArbelDirector
- Arturo ArayaDirector
- Eyal RubinExecutive Officer
- Chen SchorDirector
- Malcolm TaubDirector
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedJan 2015 · 8 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedJan 2015 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mordechai FriedmanDirector
- Anthony FiorinoExecutive Officer
- Alon PinkasDirector
- Uri YablonkaExecutive Officer, Director
- Irit ArbelDirector
- Liat SossoverExecutive Officer
- Chen SchorDirector
- Chaim LebovitsExecutive Officer
- Robert ShorrDirector
- Malcolm S. TaubDirector
- Sales commissions
- $817.6K
- Placement agents
- Maxim Group LLC
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.5MraisedJul 2014 · 11 investors · BiotechnologyRule 506(b)
▶$10.5MraisedJul 2014 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Malcolm S. TaubDirector
- Liat SossoverExecutive Officer
- Alon PinkasDirector
- Chaim LebovitsExecutive Officer
- Irit ArbelDirector
- Anthony FiorinoExecutive Officer
- Mordechai FriedmanDirector
- Chen SchorDirector
- Uri YablonkaExecutive Officer, Director
- Robert ShorrDirector
- Offering amount
- $10.5M
- Amount sold
- $10.5M
- Sales commissions
- $724.5K
- Placement agents
- Maxim Group LLC
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedMay 2014 · 8 investors · BiotechnologyRule 506(b)
▶$1.6MraisedMay 2014 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Liat SossoverExecutive Officer
- Malcolm TaubDirector
- Robert ShorrDirector
- Chaim LebovitsExecutive Officer
- Alon PinkasDirector
- Mordechai FriedmanDirector
- Chen SchorDirector
- Irit ArbelDirector
- Offering amount
- $2.5M
- Amount sold
- $1.6M
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
Robinhood24 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Stocktwits23 shared keywordsStocktwits is a social platform for investors and traders to share market news, discussions, sentiment polls, and live financial content. It aggregates breaking market news, equity coverage, and community discussions around individual stocks and crypto.
Public23 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
Seeking Alpha21 shared keywordsSeeking Alpha is a financial research platform that provides stock analysis, investment tools, and market coverage across asset classes to investors. The platform aggregates research from thousands of analysts and investors, offering ratings, articles, and investment ideas.
TradingView20 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Companies competing with Brainstorm Cell for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Brainstorm Cell do?
- BrainStorm Cell Therapeutics develops NurOwn, an autologous MSC-NTF cellular therapy platform aimed at treating neurodegenerative diseases with limited treatment options. Its cell therapy is investigational and not yet FDA approved.
- Who are Brainstorm Cell's investors?
- Brainstorm Cell's investors include Abbhi Capital.
- How much funding has Brainstorm Cell raised?
- Brainstorm Cell has disclosed $12.1M raised across 2 of its 5 known rounds.
- Where is Brainstorm Cell headquartered?
- Brainstorm Cell is headquartered in Hackensack, US.